期刊文献+

同型半胱氨酸及其酶基因多态性与脑血栓形成的关系 被引量:1

The relationship between homocysteine, polymorphism of its enzymes and cerebral thrombosis
下载PDF
导出
摘要 目的探讨血浆同型半胱氨酸(Hcy)及其代谢酶N5,10亚甲基四氢叶酸还原酶(MTHFR)和胱硫醚β合成酶(CBS)基因多态性与脑血栓形成的关系。方法对87例脑血栓形成患者和80例对照者,应用高效液相色谱荧光法测定血浆Hcy浓度,应用聚合酶链限制性内切酶片段长度多态性分析和扩增阻滞突变体系法检测MTHFR及CBS基因型。结果病例组血浆Hcy浓度为(15.28±4.33)μmol/L,显著高于对照组的(11.32±3.86)μmol/L(P<0.001);不同基因型对血浆Hcy浓度影响不一致;两组间基因型分布、纯合子频率和等位基因频率无显著性差异(P>0.05)。结论血浆Hcy浓度升高是脑血栓形成的独立危险因素,单纯的MTHFR和CBS突变不能被确定为脑血栓形成的独立遗传危险因素。 Objective To explore the relationship between plasma homocysteine (Hcy), polymorphism in 5. 10-methylenetetra hydrofolate reductase (MTHFR) and cystathionine-β-synthase (CBS), and cerebral thrombosis. Methods 87 subjects with first ever acute cerebral thrombosis and 80 controls were studied. The plasma Hcy levels were measured using high-performance liquid chro matography-fluorescence detection (HPLC-FD). The polymorphism in MTHFR was determined by a polymerase chain reaction (PCR) assay and subsequent restriction enzyme digestion and that in CBS was determined by amplification refractory mutation system (ARMS). Results The fast plasma Hcy level in the patient group was (15. 28 ± 4. 33)μmol/L significantly higher than that (11. 32±3. 86)μmol/L. in the control group (P〈0. 001). Different genotype had different influence on the plasma Hcy levels. There were no differences in genotype frequencies or allele frequencies between the patient group and control group ( P〈0.05). Conclusion Common mutations in MTHFR, CBS GBS and CBS T833C lead to hyperhomocysteinemia. Hyperhomocysteinemia. but not common mutations in MTHFR and CBS is associated with the increased incidence of cerebral thrombosis.
出处 《中国康复理论与实践》 CSCD 2005年第8期601-604,共4页 Chinese Journal of Rehabilitation Theory and Practice
基金 佛山市卫生局立项课题(No.2002027)。
关键词 同型半胱氨酸 N^5 10-亚甲基四氢叶酸还原酶 胱硫醚Β合成酶 基因多态性 脑血栓形成 homocysteine 5,10-methylenetetrahydrofolate reductase cystathionine-β-synt base polymorphism cerebral thrombosis
  • 相关文献

参考文献14

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 2廖瑛,梁奕铨,智喜梅,廖志红.高效液相色谱荧光检测法测定血浆中总同型半胱氨酸[J].色谱,2000,18(1):49-51. 被引量:21
  • 3Frosst P, Biota HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase[J]. Nat Genet, 1995,10 : 111.
  • 4Tsai MY, Hanson NQ, Schwichtenberg K, et al. Amplification refractory mutation system to identify mutations in cystathionine β-synthase deficiency[J]. Clin Chem, 1995,40 (12) : 1775-1777.
  • 5Masser PA, Taylor LM Jr, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis[J]. Ann Thorac Surg,1994,58(4):1240-1246.
  • 6Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thlols in serum and plasma; sex differences and correlation with cobalarain and folate concentrations in healthy subjects[J]. Clin Chem, 1994,40(6):873-881.
  • 7Boers GH, Smals AG, Trijbels FJ, et al. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years[J]. J Clin Invest,1983,72(6):1971-1976.
  • 8Bostom A, Brosnan JT, Hall B, et al. Net uptake of plasma homoeysteine by the rat kidney in vivo[J]. Atheroselerosis, 1995,116(1):59-62.
  • 9Wilcken DE, Gupta VJ, Reddy SG. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis[J]. Clin Sci, 1980, 58(5) :427-430.
  • 10Kannel WB. The Framingham study: ITS 50-year legacy and future promise[J]. J Atheroscler Thromb, 2000,6 (2): 60-66.

二级参考文献2

  • 1Howard E. Henderson,Shelley V. Landon,John Michie,G. Michael B. Berger. Association of a DNA polymorphism in the apolipoprotein C-III gene with diverse hyperlipidaemic phenotypes[J] 1987,Human Genetics(1):62~65
  • 2Monika Buraczynska,Janusz Hanzlik,Marek Grzywa. ApoA-I related DNA polymorphism in humans with coronary heart disease[J] 1986,Human Genetics(2):165~167

共引文献33040

同被引文献10

  • 1常爱林,毛颖.彩色双功能超声在诊断颈内动脉粥样硬化狭窄中的临床应用[J].医学影像学杂志,2005,15(8):648-650. 被引量:2
  • 2刘伟峰,张步延,黄文增,关红菁.高同型半胱氨酸血症致血管炎症作用[J].中国动脉硬化杂志,2005,13(4):464-466. 被引量:32
  • 3VanGuldener C, Stehouwer CD. Homocysteine metabolism in renal disease. Clin Chem Lab Med, 2003, 41:1412 - 1417.
  • 4Moller J, Nielsen GM, Tvedegaard KC, et al. A meta-analysis of cerebrovascular disease and hyperhomocysteinemia. Scand J Clin Lab Invest, 2000, 60:491-499.
  • 5Aronow WS, Ahn C, Gutstein H. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons. Am J Cardiol, 2000, 86:585 - 586.
  • 6Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocysteine and ischemic stroke due to large and small artery disease but not other etiologic subtypes of ischemic stroke. Stroke, 2000, 31 : 1069 - 1075.
  • 7Faraci FM, Lentz SR. Hyperhomocysteinemia ,oxidative stress and cerebral vascular dysfunction. Stroke, 2004, 35 : 345 - 347.
  • 8Riba R, Nicobou A, Troxler M, et al. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis, 2004, 175:69 - 75.
  • 9Kartal-Ozer N, Negis Y, Aytan N. Molecular mechanisms of cholesterol or homocysteine effect in the development of atherosclemsis:role of vitamin E. Biofactors, 2003, 19:63 - 70.
  • 10Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest, 2001, 107:675 - 687.

引证文献1

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部